Literature DB >> 33239721

Genomic retargeting of p53 and CTCF is associated with transcriptional changes during oncogenic HRas-induced transformation.

Michal Schwartz1,2, Avital Sarusi Portugez1, Bracha Zukerman Attia1, Miriam Tannenbaum1, Leslie Cohen1, Olga Loza1, Emily Chase1, Yousef Turman3, Tommy Kaplan4, Zaidoun Salah3, Ofir Hakim5.   

Abstract

Gene transcription is regulated by distant regulatory elements via combinatorial binding of transcription factors. It is increasingly recognized that alterations in chromatin state and transcription factor binding in these distant regulatory elements may have key roles in cancer development. Here we focused on the first stages of oncogene-induced carcinogenic transformation, and characterized the regulatory network underlying transcriptional changes associated with this process. Using Hi-C data, we observe spatial coupling between differentially expressed genes and their differentially accessible regulatory elements and reveal two candidate transcription factors, p53 and CTCF, as determinants of transcriptional alterations at the early stages of oncogenic HRas-induced transformation in human mammary epithelial cells. Strikingly, the malignant transcriptional reprograming is promoted by redistribution of chromatin binding of these factors without major variation in their expression level. Our results demonstrate that alterations in the regulatory landscape have a major role in driving oncogene-induced transcriptional reprogramming.

Entities:  

Year:  2020        PMID: 33239721      PMCID: PMC7809021          DOI: 10.1038/s42003-020-01398-y

Source DB:  PubMed          Journal:  Commun Biol        ISSN: 2399-3642


  68 in total

Review 1.  Transcriptional Addiction in Cancer.

Authors:  James E Bradner; Denes Hnisz; Richard A Young
Journal:  Cell       Date:  2017-02-09       Impact factor: 41.582

Review 2.  3D view of chromosomes, DNA damage, and translocations.

Authors:  Michal Schwartz; Ofir Hakim
Journal:  Curr Opin Genet Dev       Date:  2014-03-12       Impact factor: 5.578

Review 3.  Targeting transcription factors: promising new strategies for cancer therapy.

Authors:  Jennifer E Yeh; Patricia A Toniolo; David A Frank
Journal:  Curr Opin Oncol       Date:  2013-11       Impact factor: 3.645

4.  BEDTools: a flexible suite of utilities for comparing genomic features.

Authors:  Aaron R Quinlan; Ira M Hall
Journal:  Bioinformatics       Date:  2010-01-28       Impact factor: 6.937

Review 5.  The role of enhancers in cancer.

Authors:  Inderpreet Sur; Jussi Taipale
Journal:  Nat Rev Cancer       Date:  2016-07-01       Impact factor: 60.716

Review 6.  The nuclear oncoprotein Fra-1: a transcription factor knocking on therapeutic applications' door.

Authors:  Francesco Talotta; Laura Casalino; Pasquale Verde
Journal:  Oncogene       Date:  2020-05-08       Impact factor: 9.867

7.  TP53 engagement with the genome occurs in distinct local chromatin environments via pioneer factor activity.

Authors:  Morgan A Sammons; Jiajun Zhu; Adam M Drake; Shelley L Berger
Journal:  Genome Res       Date:  2014-11-12       Impact factor: 9.043

8.  Causal analysis approaches in Ingenuity Pathway Analysis.

Authors:  Andreas Krämer; Jeff Green; Jack Pollard; Stuart Tugendreich
Journal:  Bioinformatics       Date:  2013-12-13       Impact factor: 6.937

9.  The long-range interaction landscape of gene promoters.

Authors:  Amartya Sanyal; Bryan R Lajoie; Gaurav Jain; Job Dekker
Journal:  Nature       Date:  2012-09-06       Impact factor: 49.962

10.  DNA methylation of distal regulatory sites characterizes dysregulation of cancer genes.

Authors:  Dvir Aran; Sivan Sabato; Asaf Hellman
Journal:  Genome Biol       Date:  2013-03-12       Impact factor: 13.583

View more
  1 in total

1.  Epithelial cells remove precancerous cells by cell competition via MHC class I-LILRB3 interaction.

Authors:  Nagisa Kamoshita; Jun Nakayama; Shiyu Ayukawa; Ryohei Teramoto; Novalia Pishesha; Kenji Ohba; Nanami Sato; Kei Kozawa; Hikari Abe; Kentaro Semba; Nobuhito Goda; Yasuyuki Fujita; Takeshi Maruyama
Journal:  Nat Immunol       Date:  2021-10-22       Impact factor: 31.250

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.